Variation in management of immune suppression after allogeneic hematopoietic cell transplantation.
about
Tolerance associated gene expression following allogeneic hematopoietic cell transplantation.Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host diseasePharmacokinetics, Pharmacodynamics and Pharmacogenomics of Immunosuppressants in Allogeneic Haematopoietic Cell Transplantation: Part ISuccess of an International Learning Health Care System in Hematopoietic Cell Transplantation: The American Society of Blood and Marrow Transplantation Clinical Case Forum.Uptake and use of recommendations for the diagnosis, severity scoring and management of chronic GVHD: an international survey of the EBMT-NCI Chronic GVHD Task Force.Insights on practice variations in the management of lymphoma and leukemia.Comparison of graft-versus-host disease-free, relapse-free survival of transplantation using matched sibling donor, matched unrelated donor or unrelated cord blood after myeloablative conditioning for adult patients with hematological malignancies.'Real-life' report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO).Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host Disease.Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis.
P2860
Q35182401-BF61050D-2FB0-45D0-A4BB-6A50DF738E7AQ35800856-D12BBC75-EABA-4EA5-9CA9-15A57997C198Q36777599-23BAA202-2AA6-491E-B451-5397AB5D412EQ37136301-14B2C62D-3DD2-4D0B-88B2-B9FA1E634BA9Q37626094-66E22D7C-6245-46C4-BB49-3AC32EF7AF4DQ38177354-E511D077-2FCC-4907-9CE3-EC4EB7EEF671Q40106226-1D0B6ED7-E22E-4915-849D-47B656B5E067Q48102813-12F3EDC1-B677-4CE7-847C-151471E63DE7Q50043532-AE340C4D-52B7-4EC7-ADB2-73A3C32B4401Q52642082-4CCCC619-3538-4588-B0FD-5960185B7998
P2860
Variation in management of immune suppression after allogeneic hematopoietic cell transplantation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Variation in management of imm ...... opoietic cell transplantation.
@ast
Variation in management of imm ...... opoietic cell transplantation.
@en
type
label
Variation in management of imm ...... opoietic cell transplantation.
@ast
Variation in management of imm ...... opoietic cell transplantation.
@en
prefLabel
Variation in management of imm ...... opoietic cell transplantation.
@ast
Variation in management of imm ...... opoietic cell transplantation.
@en
P2093
P2860
P1476
Variation in management of imm ...... opoietic cell transplantation.
@en
P2093
Claudio Anasetti
Gwen Quinn
Heather Jim
Jongphil Kim
Joseph Pidala
P2860
P304
P356
10.1016/J.BBMT.2011.03.006
P577
2011-04-11T00:00:00Z